Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
05 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/04/3110212/0/en/Nxera-Pharma-to-Receive-US-4-8-Million-in-Milestone-Payments-Following-Centessa-s-Initiation-of-Clinical-Development-of-ORX142-a-Novel-Orexin-Receptor-2-OX2R-Agonist.html
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3092403/0/en/Nxera-Pharma-to-Receive-US-15-Million-from-Neurocrine-Biosciences-Following-Dosing-of-First-Patient-in-Phase-3-Trial-of-NBI-1117568.html
01 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/01/3091514/0/en/Nxera-Pharma-Achieves-Development-Milestone-in-Collaboration-with-Eli-Lilly-Targeting-Metabolic-Diseases.html
28 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/28/3090018/0/en/Nxera-Pharma-Notes-Neurocrine-Biosciences-Presents-New-Positive-Data-from-Phase-2-Study-of-NBI-1117568-in-Adults-with-Schizophrenia-at-American-Society-of-Clinical-Psychopharmacolo.html
02 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/02/3073029/0/en/Nxera-Pharma-Operational-Highlights-and-Consolidated-Results-for-the-First-Quarter-2025.html
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3072013/0/en/Nxera-Pharma-s-Partner-Neurocrine-Biosciences-Initiates-Phase-3-Registrational-Program-of-NBI-1117568-as-a-Potential-Treatment-for-Adults-with-Schizophrenia.html
ABOUT THIS PAGE